Ted Jenkins | VP, IR |
Ankit Mahadevia | Co-Founder, CEO, President & Director |
David Melnick | Chief Medical Officer |
Cristina Larkin | COO |
Satyavrat Shukla | CFO |
Lyla Youssef | Cowen and Company |
Louise Chen | Cantor Fitzgerald & Co. |
Kevin DeGeeter | Oppenheimer |
Esther Hong | Berenberg |
Raghuram Selvaraju | H.C. Wainwright & Co. |
Good day, everyone, and thank you for standing by. Welcome to the Spero Therapeutics Second Quarter 2021 Earnings Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Ted Jenkins, Vice President, Head of Investor Relations at Spero Therapeutics. Mr.